High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis
Rheumatology Mar 19, 2018
Karpouzas GA, et al. - Authors aimed to assess if in rheumatoid arthritis (RA), pro-inflammatory cytokines and high-sensitivity cardiac troponin I (hs-cTnI) (a biomarker of myocardial injury) correlated with plaque burden and cardiovascular events (CVEs). Findings suggested that in patients with RA, plasma hs-cTnI was independently associated with occult coronary plaque burden, composition, and long-term incident CVEs. A lower risk for both extensive atherosclerosis and CVEs was forecasted by low hs-cTnI. Therefore, cardiovascular risk stratification in RA could be optimized by the hs-cTnI.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries